Edition:
United Kingdom

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

72.04USD
17 Aug 2018
Change (% chg)

$0.46 (+0.64%)
Prev Close
$71.58
Open
$71.39
Day's High
$72.14
Day's Low
$71.08
Volume
534,111
Avg. Vol
714,959
52-wk High
$76.51
52-wk Low
$60.53

Chart for

About

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $34,277.83
Shares Outstanding(Mil.): 544.87
Dividend: 0.16
Yield (%): 1.02

Financials

  BAX.N Industry Sector
P/E (TTM): 38.37 32.30 32.76
EPS (TTM): 1.64 -- --
ROI: 6.78 13.94 14.61
ROE: 10.22 16.79 16.33

UPDATE 1-Smiths Group, ICU Medical close to abandoning healthcare merger -Sky News

Aug 7 British engineering firm Smiths Group Plc is close to abandoning talks with U.S.-based ICU Medical Inc over a 7 billion pound ($9 billion) merger of their healthcare divisions, Sky News reported on Monday.

07 Aug 2018

BRIEF-Baxter Declares Dividend And Announces Quarterly Dividend Increase

* BAXTER DECLARES DIVIDEND AND ANNOUNCES QUARTERLY DIVIDEND INCREASE

08 May 2018

BRIEF-Baxter International Posts Q1 GAAP Earnings Per Share $0.71 From Continuing Operations

* BAXTER REPORTS FIRST-QUARTER 2018 RESULTS AND INCREASES FINANCIAL OUTLOOK FOR FULL-YEAR 2018

26 Apr 2018

BRIEF-Ameren CEO Warner Baxter's 2017 Total Compensation Was $8.1 Mln‍​

* AMEREN CORP CEO WARNER L. BAXTER'S 2017 TOTAL COMPENSATION WAS $8.1 MILLION VERSUS $6.6 MILLION IN 2016 – SEC FILING‍​ Source text - http://bit.ly/2FOolXi Further company coverage:

19 Mar 2018

BRIEF-Baxter Announces Dividend, Additional Share Repurchase

* BAXTER DECLARES QUARTERLY DIVIDEND AND ANNOUNCES EXPANDED SHARE REPURCHASE AUTHORIZATION

20 Feb 2018

Earnings vs. Estimates